(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

VALUMEDS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

VALUMEDS

ST13

US500000087400993

Class

5

Filing

87400993

Registration

5316587

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

20

Latest update

02/12/2025

Trademark type

Word

Nice classes

5

Filing date

04/06/2017

Registration date

10/24/2017

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/26/2023

Last transaction

06/26/2023

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

First use anywhere

01/31/2013

First use in commerce

01/31/2013

Drawing code

4

Owner type

03

Owner location

RONKONKOMA, NY

Examiner

ROSSMAN, WILLIAM M

Law office

L90

Current location

TMEG LAW OFFICE 109

Holders and representatives

Holders

PRODOSE, INC.
Spirit Pharmaceuticals, LLC

Representatives

James J. Bitetto Tutunjian & Bitetto, P.C.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Allergy medications; Allergy relief medication; Amino acid preparations for medical purposes; Amino acids for nutritional purposes; Anesthetic for surgical purposes; Anesthetics for non-surgical use; Anesthetics for surgical and non-surgical use; Antibiotic creams; Antibiotic handwash; Antibiotic ointments; Antibiotic preparations; Antibiotic tablets; Antibiotics; Antifungal creams for medical use; Antihistamines; Calcium supplements; Contraceptive foams; Contraceptive preparations; Contraceptive sponges; Dental amalgams; Dental impression materials; Dental polish; Dental tablets for disclosing plaque and tartar on the teeth; Dental waxes; Deodorizing productsall purpose deodorizer preparations for householdcommercial and industrial use; Diagnostic agentspreparations and substances for medical purposes; Diagnostic preparations for medical purposes; Diarrhea medication; Diet capsules; Diet pills; Dietary and nutritional supplements; Dietary beverage supplements for human consumption in liquid and dry mix form for therapeutic purposes; Dietary supplements consisting primarily of calcium; Dietary supplements for human consumption; Electrolyte drinks for medical purposes; Electrolyte replacement solutions; Enzyme dietary supplements; Enzymes for medical purposes; Eye washes; Eye-washes; Fungicides for medical use; Hair growth stimulants; Hemorrhoid treatment preparations; Hemorrhoidal ointments; Herbal supplements; Herbal supplements for sleeping problems; Material for repairing teeth and for dental crowns and bridges; Medical lubricantvaginal lubricants; Medicated anti-cavity dental rinses; Medicated dental rinses; Medicated diaper rash ointments and lotions; Medicated hair care preparations; Medicated lotions for treating dermatological conditions; Medicines for dental purposes; Migraine treatment preparations; Mixed antibiotic preparations; Molding wax for dental use; Nail fungus treatment preparations; Nutritional supplements consisting primarily of calcium; Oral contraceptives; Orthodontic alginate for dental impressions; Pain relief medication; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous systemthe immune systemthe cardio-vascular systemthe metabolic systemthe respiratory systemthe musculo-skeletal systemthe genitourinary systemfor the treatment of inflammatory disordersfor use in dermatologyoncologyhematology and in tissue and organ transplantationin ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseasesbacteria-based diseases or disordersautoimmune diseases or disorderskidney diseases or disordersdiabetes; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseasesfor the treatment of bacteria-based diseasesfor the treatment of diabetesanti - infective preparationsantiviral preparationsantibioticsantifungal preparations and vaccines; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorderssports related injuriesfor knee cartilage regeneration; Pharmaceutical preparations for treating dandruff; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for wounds; Pharmaceutical preparationsan analgesic for human consumption taken orally; Pharmaceutical preparationsanticoagulants; Pharmaceutical preparationsantidepressants; Pharmaceutical preparationsappetite suppressants; Pharmaceuticalsanti-infectives; Room deodorants; Sleeping pills/tablets ; Topical anesthetics; Vaginal preparationsantifungals

Publications

History of USPTO decisions and trademark events.

20 publications found

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

02/12/2025

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

06/26/2023

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

06/26/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/14/2023

E815

TEAS SECTION 8 & 15 RECEIVED

12/13/2022

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

10/26/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/26/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/26/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/26/2022

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

10/26/2022

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

10/24/2022

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

08/10/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

10/24/2017

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/08/2017

PUBO

PUBLISHED FOR OPPOSITION

08/08/2017

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/19/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/28/2017

DOCK

ASSIGNED TO EXAMINER

06/28/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/13/2017

NWAP

NEW APPLICATION ENTERED

04/10/2017

Continuous trademark protection

Get notified about every new filing that threatens VALUMEDS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.